Clinical Trial Update: Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating plasmapheresis for drug-induced liver injury in patients with chronic liver disease, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury
• Liver Disease

Drugs mentioned

• plasmapheresis

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Drug Induced Liver Injury, Chronic Liver Disease | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING